EMA: Draft vortioxetine hydrobromide, 5 mg, 10 mg, 15 mg and 20 mg immediate release tablets, vortioxetine lactate, oral drops solution 20 mg/ml product-specific bioequivalence guidance

This document provides product-specific guidance on the demonstration of the bioequivalence of vortioxetine hydrobromide and vortioxetine lactate.